39 related articles for article (PubMed ID: 35959113)
1. miR-1207-3p Is a Novel Prognostic Biomarker of Prostate Cancer.
Das DK; Osborne JR; Lin HY; Park JY; Ogunwobi OO
Transl Oncol; 2016 Jun; 9(3):236-41. PubMed ID: 27267842
[TBL] [Abstract][Full Text] [Related]
2. The value of a panel of circulating microRNAs in screening prostate cancer.
Sun C; Lu C; Li X; Li R; Wen Z; Ge Z; Chen W; Li Y; Sun S; Yang Q; Tao L; Li H; Lai Y
Transl Cancer Res; 2024 Feb; 13(2):686-698. PubMed ID: 38482417
[TBL] [Abstract][Full Text] [Related]
3. Role of Metastasis-Related microRNAs in Prostate Cancer Progression and Treatment.
Oh-Hohenhorst SJ; Lange T
Cancers (Basel); 2021 Sep; 13(17):. PubMed ID: 34503302
[TBL] [Abstract][Full Text] [Related]
4. A novel prognostic model based on three clinic-related miRNAs for prostate cancer.
Che P; Jiang S; Zhang W; Zhu H; Hu D; Wang D
Front Surg; 2022; 9():872953. PubMed ID: 35959113
[TBL] [Abstract][Full Text] [Related]
5. Establishing a three-miRNA signature as a prognostic model for colorectal cancer through bioinformatics analysis.
Wang Y; Huang L; Shan N; Ma H; Lu S; Chen X; Long H
Aging (Albany NY); 2021 Aug; 13(15):19894-19907. PubMed ID: 34388112
[TBL] [Abstract][Full Text] [Related]
6. Identification of a three-miRNA signature as a novel prognostic model for papillary renal cell carcinoma.
Li G; Yang H; Cheng Y; Zhao X; Li X; Jiang R
Cancer Cell Int; 2020; 20():317. PubMed ID: 32694939
[TBL] [Abstract][Full Text] [Related]
7. Different levels of serum microRNAs in prostate cancer and benign prostatic hyperplasia: evaluation of potential diagnostic and prognostic role.
Cochetti G; Poli G; Guelfi G; Boni A; Egidi MG; Mearini E
Onco Targets Ther; 2016; 9():7545-7553. PubMed ID: 28008272
[TBL] [Abstract][Full Text] [Related]
8. Comparative analysis of epi-miRNA expression levels in local/locally advanced and metastatic prostate cancer patients.
Gurbuz V; Kiliccioglu I; Dikmen AU; Bilen CY; Sozen S; Konac E
Gene; 2020 Oct; 758():144963. PubMed ID: 32683077
[TBL] [Abstract][Full Text] [Related]
9. Identification of microRNAs as novel biomarkers for esophageal squamous cell carcinoma: a study based on The Cancer Genome Atlas (TCGA) and bioinformatics.
Li CY; Zhang WW; Xiang JL; Wang XH; Li J; Wang JL
Chin Med J (Engl); 2019 Sep; 132(18):2213-2222. PubMed ID: 31490264
[TBL] [Abstract][Full Text] [Related]
10. LncRNA FGF14-AS2 represses growth of prostate carcinoma cells via modulating miR-96-5p/AJAP1 axis.
Li R; Chen Y; Wu J; Cui X; Zheng S; Yan H; Wu Y; Wang F
J Clin Lab Anal; 2021 Nov; 35(11):e24012. PubMed ID: 34655124
[TBL] [Abstract][Full Text] [Related]
11. Prostate cancer dormancy and recurrence.
Cackowski FC; Heath EI
Cancer Lett; 2022 Jan; 524():103-108. PubMed ID: 34624433
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-21 deficiency suppresses prostate cancer progression through downregulation of the IRS1-SREBP-1 signaling pathway.
Kanagasabai T; Li G; Shen TH; Gladoun N; Castillo-Martin M; Celada SI; Xie Y; Brown LK; Mark ZA; Ochieng J; Ballard BR; Cordon-Cardo C; Adunyah SE; Jin R; Matusik RJ; Chen Z
Cancer Lett; 2022 Jan; 525():46-54. PubMed ID: 34610416
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-182-5p and microRNA-205-5p as potential biomarkers for prognostic stratification of p16-positive oropharyngeal squamous cell carcinoma.
Weiss BG; Anczykowski MZ; Ihler F; Bertlich M; Spiegel JL; Haubner F; Canis M; Küffer S; Hess J; Unger K; Kitz J; Jakob M
Cancer Biomark; 2022; 33(3):331-347. PubMed ID: 34542062
[TBL] [Abstract][Full Text] [Related]
14. Identification of asthma-associated microRNAs in bronchial biopsies.
Roffel MP; Boudewijn IM; van Nijnatten JLL; Faiz A; Vermeulen CJ; van Oosterhout AJ; Affleck K; Timens W; Bracke KR; Maes T; Heijink IH; Brandsma CA; van den Berge M
Eur Respir J; 2022 Mar; 59(3):. PubMed ID: 34446467
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
